EZETIMIBE

Course overview

EZETIMIBE IS A MEDICATION USED IN THE MANAGEMENT AND TREATMENT OF HYPERCHOLESTEROLEMIA. IT IS AMONG A NOVEL CLASS OF SELECTIVE CHOLESTEROL-ABSORPTION INHIBITORS. IT IS INDICATED TO REDUCE TOTAL CHOLESTEROL, LOW-DENSITY LIPOPROTEIN (LDL), APOLIPOPROTEIN B (APO B), AND NON-HIGH-DENSITY LIPOPROTEIN (HDL) IN PATIENTS WITH PRIMARY HYPERLIPIDEMIA, MIXED HYPERLIPIDEMIA, FAMILIAL HYPERCHOLESTEROLEMIA (HOFH), AND HOMOZYGOUS SITOSTEROLEMIA (PHYTOSTEROLEMIA). THIS ACTIVITY DESCRIBES THE INDICATIONS, ACTIONS, AND CONTRAINDICATIONS FOR EZETIMIBE AS A VALUABLE AGENT IN TREATING HYPERCHOLESTEROLEMIA. IN ADDITION, THIS ACTIVITY HIGHLIGHTS THE ADMINISTRATION AND MONITORING PRINCIPLES THAT THE INTERPROFESSIONAL TEAM SHOULD EMPLOY TO MANAGE PATIENTS WITH HYPERCHOLESTEROLEMIA USING EZETIMIBE.